Our latest news, updates, announcements and media resources

Enova Maestro®: Redefining Visual Outcomes After Cataract Surgery

Presbyopia continues to be one of the most significant visual limitations following cataract surgery, even with the use of advanced monofocal or extended-depth intraocular lenses (IOLs).

Enova Advanced® EDoF IOL: Next-Generation Vision with Light Tailoring Technology

The Enova Advanced® Extended Depth of Focus (EDoF) IOL, developed by VSY Biotechnology GmbH, represents a significant evolution in intraocular lens technology.

VSY Biotechnology GmbH Showcases Premium IOL Innovations at ESCRS 2025

At ESCRS 2025, VSY Biotechnology GmbH highlighted its latest innovations in premium intraocular lenses (IOLs), demonstrating its continued leadership in vision care solutions.

VSY Biotechnology GmbH Announces Ophthalmology Star Awards 2025 Winners at ESCRS Congress

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has officially announced the winners of the Ophthalmology Star Awards 2025 (OSA).

Enova® IOL Family: Advancing Safety and Efficiency in Daily Ophthalmic Practice

The Enova® IOL Family has been developed as a unified system that meets the demands of modern cataract and refractive surgery.

Elevating Outcomes Through Precision: The Enova IOL Family

In the field of ophthalmology, particularly with premium intraocular lenses (IOLs), patient satisfaction is most often determined by one critical factor: proper candidate selection.

VSY Biotechnology Launches Enova Hydrophobic IOLs Featuring Patented Rotaryjet™ Technology

VSY Biotechnology GmbH has officially launched its latest innovation in cataract surgery: the Enova Hydrophobic Intraocular Lenses (IOLs), enhanced with the company's patented Rotaryjet™ Preloaded Delivery System.

VSY Biotechnology's Enova® Premium IOLs Set New Standard with 100% Glistening-Free Technology

VSY Biotechnology GmbH's groundbreaking Enova® intraocular lens is reshaping expectations in the ophthalmic industry.

VSY Biotechnology Enters the Japanese Market!

Sinusoidal Trifocal Technology® developed by VSY Biotechnology GmbH has been officially approved in Japan.

VSY Biotechnology Unveils New IOL Innovation

VSY Biotechnology GmbH, one of Germany's leading manufacturers in the field of intraocular lenses (IOLs), has announced a major innovation set to significantly improve the quality of life for patients undergoing lens implantation.

Maestro®: The Sinusoidal IOL

VSY Biotechnology completes the global rollout of its Sinusoidal Vision Technology (SVT®) at ESCRS 2024.

Strategic Partnership with Clarius Mobile Health Corp.

VSY Biotechnology GmbH, a renowned player in the biotechnology and medical device sector, partners with Clarius Mobile Health Corp.

Winners of the Ophthalmology Star Awards 2024 (OSA)

The winners of the Ophthalmology Star Awards 2024 (OSA) were announced at the ESCRS Congress.

10% Is Only The Beginning: VSY Biotechnology's Protectalon Dominates German Cataract Surgeries

VSY Biotechnology GmbH is proud to announce a significant achievement in the German market.

VSY Biotechnology's In-House 100% Glistening-Free IOL Material Redefines the IOL Market

VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material.

Prof. Dr. Ike Ahmed's Experience with the Golden Ratio

Prof. Dr. Ike Ahmed, who uses the latest technologies in the field of ophthalmology, shares his experience with the Golden Ratio.

VSY Biotechnology Ophthalmology Star Awards (OSA) 2022 at ESCRS

We are glad to announce VSY Biotechnology Ophthalmology Star Awards (OSA) 2022 at this year's ESCRS.

We Have Been Awarded MDSAP Certification

We are proud to announce that we have been awarded certification for the Quality Management System audit under the MDSAP.

Sinusoidal Vision Technology (SVT®) Has Been Officially Patented in China

VSY Biotechnology registered a patent with the People's Republic of China for the Sinusoidal Vision Technology (SVT®).

VSY Biotechnology Ophthalmology Star Awards (OSA) 2021 Winners

This year's Ophthalmology Star Awards is announced at the VSY Biotechnology Satellite Symposium at ESCRS.

VSY Biotechnology Launched Acriva UD Trinova Pro C at ESCRS 2021

The first and only trifocal presbyopia-correcting intraocular lens (PC-IOL) with patented enhanced technology.

Discover the Golden Ratio in IOL Technology™

Join us at the upcoming ESCRS congress to discover how VSY Biotechnology reaches the Golden Ratio.

Golden Ratio in Trifocal IOL Technology™: Acriva UD Trinova Pro C

VSY Biotechnology introduces the new concept of Golden Ratio in IOL Technology™ with its unique design.

VSY Biotechnology's Invention Registered by the European Patent Institute

VSY Biotechnology's invention, the Rotaryjet Preloaded Injector containing an accessory system, has been registered by the European Patent Institute.

Enova® is Available Now in C Haptic Model

VSY Biotechnology announces the launch of the Enova® C Haptic Model IOL.

VSY Biotechnology GmbH Signs Agreement with WAKAMOTO PHARMACEUTICAL

Leinfelden-Echterdingen, Germany, March 19, 2021 — VSY Biotechnology GmbH announced an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. on intraocular lens products.